LATEST ALERTSNo food item should contain any cannabinoid, including CBD, in the EU without prior novel food ingredient authorisation following a change by European authorities – though this is open to interpretation
Michigan legislators have passed what is thought to be the first US law specifically exempting CBD products from state medical cannabis regulations
Researchers in Portugal have developed an algorithm to identify characteristics that suggest the nations most likely to legalise recreational cannabis
An unconfirmed seizure of products from a shop in Arizona could be the first instance of enforcement on CBD by Food and Drug Administration (FDA) officials since the passage of the US 2018 Farm Bill
Mexico may well become the third country in the world to fully legalise all cannabis products, including marijuana. In the meantime, CBD and hemp-containing products are allowed as long as they contain less than 1% THC
The Canadian government has released proposed regulations for additional products containing cannabis-derived ingredients, including food items, beverages, extracts and topicals
New Zealand could become a new market for CBD following loosening of restrictions in the country, explained in a new report from CBD-Intel
CBD-Intel guides you through the small print of CBD regulation in New Zealand, where CBD is classed as medicinal and the only part of the hemp plant that can be used in food is the seeds
The co-founder of an online CBD shop has accused rivals of deceptive marketing. Johan Obel of TheDrug.Store also called for more clarity – and tighter controls – over what is and is not legal in the UK
The Italian government has responded to confusion over permitted THC levels in hemp-derived products such as foods, oils, supplements and animal feeds by informing the European Commission of its plans
When can a health claim be made in an advertisement for a CBD product in the UK? CBD-Intel considers how the advertising codes may be legally applied in practice
The CBD industry is currently navigating a complex and changing regulatory landscape across the European Union. CBD-Intel brings some light to the obscure area of novel food regulation – and asks the vital questions
The regulation of CBD in Hungary is highly indistinct, with little direct legislation and no guidance offered by the authorities. CBD-Intel guides you through the known unknowns and the unknown knowns
The US Congress is expected to address the legal situation of CBD and cannabis during the upcoming congressional session, according to a number of experts interviewed by CBD-Intel
Pro-cannabis measures are expected to receive at least 18 more votes of support in the new US Congress, according to exclusive research by CBD-Intel, with more than 60 new Representatives supporting legalisation
While CBD has been one of THE stories of 2018, the novelty phase is now over, and 2019 will be the year the longer-term future of CBD products becomes clearer. CBD-Intel looks at prospects for the months ahead
Removing hemp from the federal narcotics Schedule 1 list does not mean that all CBD products are now permitted, the US Food and Drug Administration (FDA) has warned
The use of any cannabis extract in cosmetics is forbidden in Austria, authorities have recently confirmed
Industrial hemp farming is tolerated by Chinese authorities, but there is a lack of regulatory clarity; there is currently no mandatory national legislation for industrial hemp in China. Regional provinces that have historically been engaged with the hemp industry have been implementing supportive legislation; regional regulations impose varying restrictions on the extraction and manufacture of industrial hemp.
New national standards from the Ministry of Agriculture and Rural Affairs of the People’s Republic of China are indicative of a more favourable approach towards hemp; in some regions, local authorities might required advance notification before engaging in CBD-related activities.
Finished products made from industrial hemp/CBD are primarily developed and sold by a single company in China.
New York state has set out a series of new regulatory requirements for businesses wanting to produce or sell CBD products in its jurisdiction, with strict manufacturing, reporting and product category guidelines
The US Congress has approved a compromise version of the 2018 Farm Bill which will remove industrial hemp from the federal narcotics Schedule 1 list, potentially giving a green light to development of the CBD industry
A Canadian company is facing the prospect of losing its licence to produce and sell cannabis products. It would mark the first time Health Canada has revoked a licence since the country began regulating medical marijuana
The merger of two companies in the US CBD sector – Level Brands and Cure Based Developments – is dependent on the US Farm Bill legalising CBD at federal level
A case on the legality of selling CBD-based products in France has been referred to the Court of Justice of the European Union (CJEU)
In our latest regulatory snapshot, we look at Austria where in general the extraction and manufacture of CBD is allowed and hemp can be grown as long as the variety is on some of the key approved lists
CBD-Intel provides an easy-to-digest snapshot of the regulations governing the planting, growing, import, export and sale of various types of CBD product in Italy
The CBD-based epilepsy drug Epidiolex could become available in Europe, manufactured from cannabis already growing in eastern England
Australia is a highly restrictive market for CBD, with limits on growing and extraction and an absolute prohibition on CBD in consumer products. This report details what is and what is not allowed
Cultivation of hemp with less than 0.2% THC content is legal in Denmark. While some aspects of CBD regulation remain unclear, our report guides you through the rules as they are – and how they may be interpreted
Securing cannabis supplies for research purposes is the focus of an information request from the US federal government. They are asking businesses about the ability to analyse, produce, and even distribute cannabis products for research. The National Institute on Drug Abuse (NIDA) is probing for businesses that have the “in-house capability to act as a centralized source for acquisition and/or production, analysis, and distribution of cannabis and related materials for research purposes,” according to a federal notice.
The British government last week presented the 585-page draft withdrawal agreement which lays out how it intends the UK to leave the European Union. Here CBD-Intel explains just how it may affect the CBD industry
With the ousting of attorney general Jeff Sessions from the Trump administration, members of the US cannabis industry have perked up, hoping the anti-cannabis agenda will exit with him
CBD-Intel provides an easy-to-digest snapshot of the regulations governing the planting, growing, import, export and sale of various types of CBD product in Belgium
The number of cannabidiol-based pharmaceutical products in the pipeline continues to grow, with the US Food and Drug Administration (FDA) recently granting yet another orphan drug designation for CBD
The UK’s Veterinary Medicines Directorate (VMD) has told CBD-Intel that even a product not normally considered a medicine, such as a pet food or livestock feed, will be treated as a pharmaceutical if it contains CBD
In our latest look at Poland, we find that THC is a regulated substance, thus all the products on the market which have not obtained a medical authorisation must be THC-free
In our overview of the regulatory landscape in the United Kingdom we find that while the UK is one of Europe’s largest CBD markets, growing and extracting CBD is restricted and there is a zero-tolerance policy for THC content in CBD products
Police are clamping down on the new wave of CBD shops in France. Products have been confiscated and some stores have even been closed down.
Voters in Michigan have voted to legalise the recreational use of cannabis, while those in North Dakota rejected it. In Utah and Missouri medical cannabis use was approved on the day the US turned out to vote in the midterm elections
Germany was one of the first European countries to legalise medical cannabis and is a huge potential market for non-medical CBD, given its population and the range of products already available
Australia may become a big exporter of organic hemp products, especially to Asia, according to the president of the Australian Industrial Hemp Alliance (AIHA)
Medical cannabis products are now legal in the UK – in very limited circumstances. This could include products without marketing authorisation, if approved by a registered specialist in certain conditions
A founder of the UK Cannabis Trades Association (CTA) has resigned, alleging the industry body has been misleading companies about its role in regulation
Despite being Europe’s biggest hemp grower and reputedly its highest cannabis user, France has one of Europe’s most restrictive regulatory environments for cannabis use.
Comments invited by the FDA on the potential abuse and medical usefulness of CBD and other cannabis-derived substances will be submitted to the World Health Organization (WHO)
The Spanish Observatory of Medicinal Cannabis has called on the government to stop seizures of CBD oil in Spain, and demanded clear regulation of cannabis-based products
FOR IMMEDIATE RELEASE New regulations may take the shine off CBD business With all the buzz around its possible health benefits, businesses might see CBD as a lucrative opportunity – but the global market for it is complex, and changes in CBD’s legal situation may create challenges for business, experts at CBD-Intel have warned. The legal status of CBD varies » Continue Reading.
Canada’s cannabis age has officially dawned, with some CBD products as well as the plant itself becoming legal for retail and personal possession
Executive summary Canada is the centre for the world’s largest cannabis companies and has recently implemented a wide-ranging new regulatory environment for all cannabis products. However, the new cannabis legislation treats CBD in exactly the same way as THC-containing products. Under the Cannabis Act Only licence holders will be allowed to extract CBD, and CBD products » Continue Reading.
In this overview of Swiss CBD regulation, we find that THC content is limited to 0.3% in cannabis plants and 1% in finished products, significantly higher than most neighbouring countries
Stay up-to-date with key market trends and regulatory news and receive complimentary data on a regular basis.
"*" indicates required fields
Get 7 days of access to industry updates through our news analysis and regulatory alerts
"*" indicates required fields
